{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:17:15Z","timestamp":1782231435256,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00330-020-06919-1","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T13:02:47Z","timestamp":1590066167000},"page":"5588-5598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities"],"prefix":"10.1007","volume":"30","author":[{"given":"Ryo","family":"Kurokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5018-4683","authenticated-orcid":false,"given":"Wataru","family":"Gonoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiko","family":"Isshiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Matsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harushi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"6919_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3960\/jslrt.53.63","volume":"53","author":"K Takai","year":"2013","unstructured":"Takai K, Nikkuni K, Momoi A, Nagai K, Igarashi N, Saeki T (2013) Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly : a clinical report of five cases. J Clin Exp Hematop 53:63\u201368","journal-title":"J Clin Exp Hematop"},{"key":"6919_CR2","first-page":"253","volume":"12","author":"Z Islamoglu","year":"2018","unstructured":"Islamoglu Z, Duman AE, Sirin G et al (2018) TAFRO syndrome: a case report from Turkey and review of the literature. Int J Hematol Oncol Stem Cell Res 12:253\u2013259","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"6919_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13256-018-1814-9","volume":"12","author":"Y Fujiwara","year":"2018","unstructured":"Fujiwara Y, Ito K, Takamura A, Nagata K (2018) The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report. J Med Case Rep 12:295","journal-title":"J Med Case Rep"},{"key":"6919_CR4","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2169\/internalmedicine.56.7991","volume":"56","author":"M Nara","year":"2017","unstructured":"Nara M, Komatsuda A, Itoh F et al (2017) Two cases of thrombocytopenia, anasarca, fever, reticulin fibrosis\/renal failure, and Organomegaly (TAFRO) syndrome with high serum procalcitonin levels, including the first case complicated with adrenal hemorrhaging. Intern Med 56:1247\u20131252","journal-title":"Intern Med"},{"key":"6919_CR5","doi-asserted-by":"crossref","unstructured":"Finocchietto P, Contardo D, Uehara T et al (2015) TAFRO syndrome in a patient of south-American descent. Eur J Case Rep Intern Med 2","DOI":"10.12890\/000220"},{"key":"6919_CR6","doi-asserted-by":"publisher","first-page":"905.e1","DOI":"10.1016\/j.crad.2017.05.007","volume":"72","author":"T Kiguchi","year":"2017","unstructured":"Kiguchi T, Sato C, Takai K, Nakai Y, Kaneko Y, Matsuki M (2017) CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman\u2019s disease. Clin Radiol 72:905.e1\u2013905.e5","journal-title":"Clin Radiol"},{"key":"6919_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.humpath.2018.03.021","volume":"82","author":"H Mizuno","year":"2018","unstructured":"Mizuno H, Sekine A, Oguro M et al (2018) Renal histology in a patient with TAFRO syndrome: a case report. Hum Pathol 82:258\u2013263","journal-title":"Hum Pathol"},{"key":"6919_CR8","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3389\/fimmu.2019.01489","volume":"10","author":"A Leurs","year":"2019","unstructured":"Leurs A, Gnemmi V, Lionet A et al (2019) Renal pathologic findings in TAFRO syndrome: is there a continuum between thrombotic microangiopathy and membranoproliferative glomerulonephritis? A case report and literature review. Front Immunol 10:1489","journal-title":"Front Immunol"},{"key":"6919_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s13730-018-0338-x","volume":"7","author":"T Ozeki","year":"2018","unstructured":"Ozeki T, Tsuji M, Yamamoto J, Shigematsu C, Maruyama S (2018) Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome. CEN Case Rep 7:243\u2013247","journal-title":"CEN Case Rep"},{"key":"6919_CR10","doi-asserted-by":"publisher","first-page":"e8216","DOI":"10.1097\/MD.0000000000008216","volume":"96","author":"M Tanaka","year":"2017","unstructured":"Tanaka M, Tsujimoto H, Yamamoto K, Shimoda S, Oka K, Takeoka H (2017) Clinicopathological features of progressive renal involvement in TAFRO syndrome: a case report and literature review. Medicine (Baltimore) 96:e8216","journal-title":"Medicine (Baltimore)"},{"key":"6919_CR11","doi-asserted-by":"publisher","first-page":"e11045","DOI":"10.1097\/MD.0000000000011045","volume":"97","author":"T Shirai","year":"2018","unstructured":"Shirai T, Onishi A, Waki D, Saegusa J, Morinobu A (2018) Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review. Medicine (Baltimore) 97:e11045","journal-title":"Medicine (Baltimore)"},{"key":"6919_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3109\/14397595.2015.1120389","volume":"28","author":"K Sakai","year":"2018","unstructured":"Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Ueda Y (2018) TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review. Mod Rheumatol 28:564\u2013569","journal-title":"Mod Rheumatol"},{"key":"6919_CR13","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.2169\/internalmedicine.8522-16","volume":"56","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi T, Shimizu T, Toyama T, Abe R, Okamoto S (2017) Successful treatment of TAFRO syndrome with tocilizumab, prednisone, and cyclophosphamide. Intern Med 56:2205\u20132211","journal-title":"Intern Med"},{"key":"6919_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1620\/tjem.236.289","volume":"236","author":"Y Konishi","year":"2015","unstructured":"Konishi Y, Takahashi S, Nishi K et al (2015) Successful treatment of TAFRO syndrome, a variant of multicentric Castleman\u2019s disease, with cyclosporine a: possible pathogenetic contribution of interleukin-2. Tohoku J Exp Med 236:289\u2013295","journal-title":"Tohoku J Exp Med"},{"key":"6919_CR15","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1016\/S2352-3026(16)00006-5","volume":"3","author":"AY Liu","year":"2016","unstructured":"Liu AY, Nabel CS, Finkelman BS et al (2016) Idiopathic multicentric Castleman\u2019s disease: a systematic literature review. Lancet Haematol 3:e163\u2013e175","journal-title":"Lancet Haematol"},{"key":"6919_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12185-016-1979-1","volume":"103","author":"Y Masaki","year":"2016","unstructured":"Masaki Y, Kawabata H, Takai K et al (2016) Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol 103:686\u2013692","journal-title":"Int J Hematol"},{"key":"6919_CR17","first-page":"519","volume":"81","author":"T Matsuhisa","year":"2019","unstructured":"Matsuhisa T, Takahashi N, Nakaguro M et al (2019) Fatal case of TAFRO syndrome associated with over-immunosuppression: a case report and review of the literature. Nagoya J Med Sci 81:519\u2013528","journal-title":"Nagoya J Med Sci"},{"key":"6919_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ajh.24242","volume":"91","author":"N Iwaki","year":"2016","unstructured":"Iwaki N, Fajgenbaum DC, Nabel CS et al (2016) Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 91:220\u2013226","journal-title":"Am J Hematol"},{"key":"6919_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12185-019-02780-1","volume":"111","author":"Y Masaki","year":"2020","unstructured":"Masaki Y, Kawabata H, Takai K et al (2020) 2019 updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol 111:155\u2013158","journal-title":"Int J Hematol"},{"key":"6919_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"6919_CR21","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1111\/j.1440-1746.2006.04433.x","volume":"21","author":"T Hashimoto","year":"2006","unstructured":"Hashimoto T, Sugawara Y, Tamura S et al (2006) Estimation of standard liver volume in Japanese living liver donors. J Gastroenterol Hepatol 21:1710\u20131713","journal-title":"J Gastroenterol Hepatol"},{"key":"6919_CR22","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/j.ejrad.2009.08.013","volume":"75","author":"A Harris","year":"2010","unstructured":"Harris A, Kamishima T, Hao HY et al (2010) Splenic volume measurements on computed tomography utilizing automatically contouring software and its relationship with age, gender, and anthropometric parameters. Eur J Radiol 75:e97\u2013e101","journal-title":"Eur J Radiol"},{"key":"6919_CR23","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.acra.2014.06.008","volume":"21","author":"J Schneller","year":"2014","unstructured":"Schneller J, Reiser M, Beuschlein F et al (2014) Linear and volumetric evaluation of the adrenal gland--MDCT-based measurements of the adrenals. Acad Radiol 21:1465\u20131474","journal-title":"Acad Radiol"},{"key":"6919_CR24","doi-asserted-by":"publisher","first-page":"42316","DOI":"10.1038\/srep42316","volume":"7","author":"N Iwaki","year":"2017","unstructured":"Iwaki N, Gion Y, Kondo E et al (2017) Elevated serum interferon gamma-induced protein 10 kDa is associated with TAFRO syndrome. Sci Rep 7:42316","journal-title":"Sci Rep"},{"key":"6919_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.hoc.2017.09.003","volume":"32","author":"K Yoshizaki","year":"2018","unstructured":"Yoshizaki K, Murayama S, Ito H, Koga T (2018) The role of interleukin-6 in Castleman disease. Hematol Oncol Clin North Am 32:23\u201336","journal-title":"Hematol Oncol Clin North Am"},{"key":"6919_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ccr3.1430","volume":"6","author":"S Oka","year":"2018","unstructured":"Oka S, Ono K, Nohgawa M (2018) Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements. Clin Case Rep 6:644\u2013650","journal-title":"Clin Case Rep"},{"key":"6919_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/380439a0","volume":"380","author":"N Ferrara","year":"1996","unstructured":"Ferrara N, Carver-Moore K, Chen H et al (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439\u2013442","journal-title":"Nature"},{"key":"6919_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/ndt\/gfq427","volume":"26","author":"K El Karoui","year":"2011","unstructured":"El Karoui K, Vuiblet V, Dion D et al (2011) Renal involvement in Castleman disease. Nephrol Dial Transplant 26:599\u2013609","journal-title":"Nephrol Dial Transplant"},{"key":"6919_CR29","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","volume":"17","author":"MB Atkins","year":"1999","unstructured":"Atkins MB, Lotze MT, Dutcher JP et al (1999) High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 17:2105\u20132116","journal-title":"J Clin Oncol"},{"key":"6919_CR30","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1200\/JCO.1994.12.12.2714","volume":"12","author":"AS Guleria","year":"1994","unstructured":"Guleria AS, Yang JC, Topalian SL et al (1994) Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma. J Clin Oncol 12:2714\u20132722","journal-title":"J Clin Oncol"},{"key":"6919_CR31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0002-9343(90)90343-C","volume":"89","author":"PA Paciucci","year":"1990","unstructured":"Paciucci PA, Mandeli J, Oleksowicz L, Ameglio F, Holland JF (1990) Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion. Am J Med 89:308\u2013312","journal-title":"Am J Med"},{"key":"6919_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2214\/ajr.183.1.1830220","volume":"183","author":"AM Riddell","year":"2004","unstructured":"Riddell AM, Khalili K (2004) Sequential adrenal infarction without MRI-detectable hemorrhage in primary antiphospholipid-antibody syndrome. AJR Am J Roentgenol 183:220\u2013222","journal-title":"AJR Am J Roentgenol"},{"key":"6919_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fphys.2019.00251","volume":"10","author":"PS Russell","year":"2019","unstructured":"Russell PS, Hong J, Windsor JA, Itkin M, Phillips ARJ (2019) Renal lymphatics: anatomy, physiology, and clinical implications. Front Physiol 10:251","journal-title":"Front Physiol"},{"key":"6919_CR34","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1182\/blood-2013-12-545087","volume":"123","author":"DC Fajgenbaum","year":"2014","unstructured":"Fajgenbaum DC, van Rhee F, Nabel CS (2014) HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood 123:2924\u20132933","journal-title":"Blood"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-06919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-020-06919-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-06919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T23:20:22Z","timestamp":1621552822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-020-06919-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["6919"],"URL":"https:\/\/doi.org\/10.1007\/s00330-020-06919-1","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]},"assertion":[{"value":"13 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Osamu Abe.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 diagnostic or prognostic study\u2022 multi-centre study","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}